[Clinical trial of chemotherapeutic combinations based on the notion of attempted cellular synchronization. Preliminary administration of an antimitotic followed by the use of cycle-dependent or phase dependent product(s)].
D000606:Amino Sugars / Q000008:administration & dosage; D000880:Anthraquinones / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001215:Asparaginase / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004247:DNA / Q000096:biosynthesis; D003630:Daunorubicin / Q000008:administration & dosage; D004338:Drug Combinations; D004361:Drug Tolerance; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D008938:Mitosis; D009362:Neoplasm Metastasis / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011035:Podophyllum; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis; D013997:Time Factors
D000606:Amino Sugars; D000880:Anthraquinones; D000970:Antineoplastic Agents; D004338:Drug Combinations; D003520:Cyclophosphamide; D004247:DNA; D001215:Asparaginase; D011241:Prednisone; D006918:Hydroxyurea; D003630:Daunorubicin
Essai clinique de combinaisons chimiothérapiques basées sur la notion de tentative de syndhronisation cellulaire. Administration première d'un antimitotique suivie de l'application de produit(s) cycle ou phase dépendant(s.